BMS-351

Overview

BMS-351 (compound 18) is a potent, oral active, nonsteroidal CYP17A1 lyase inhibitor with the IC 50 values of 19 nM and 4 nM aganist human CYP17A1 and cynomolgus monkeys CYP17A1 ,respectively. BMS-351 can be used for the study of castration-resistant prostate cancer .

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Drug Resistance | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Cytochrome P450

Product Information

• Catalog No.: HY-117529
• CAS No.: 1370001-71-0
• Molecular Formula: C15H12F3N3
• Molecular Weight: 291.27
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source